http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10e6cd35696278c094d672e080ee9732
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Czuczman |
| name | Myron S. Czuczman Myron S Czuczman |
| given-name | Myron S Myron S. |
| organization-name | From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Lymphoma Clinical Research, Wilmot Cancer Center, Rochester; Department of Medicine, Lymphoma/Myeloma Service, Roswell Park Cancer Institute, Buffalo; Division of Hematologic Oncology, Lymphoma Service, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, New York, NY; Department of Information Sciences,... Oliver W. Press, Joseph M. Unger, Michael LeBlanc, Ajay K. Gopal, David G. Maloney, Fred Hutchinson Cancer Research Center; Oliver W. Press, Ajay K. Gopal, David G. Maloney, University of Washington Medical Center, Seattle, WA; Lisa M. Rimsza, Catherine Spier, Thomas P. Miller, University of Arizona, Tucson, AZ; Jonathan W. Friedberg, Richard I. Fisher, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY; Myron S. Czuczman, Roswell Park Cancer Institute, Buffalo, NY;... Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, NY; Martin Hutchings, Annika Loft, and Lena Specht, Rigshospitalet, Copenhagen, Denmark; Lale Kostakoglu and Richard Stern, Mount Sinai Medical Center; Morton Coleman, Weill Cornell Medical College/New York Presbyterian Hospital, New York; Dominick Lamonica and Myron S. Czuczman, Roswell Park Cancer Institute, Buffalo, NY; Jan Maciej Zaucha and Iwona Danielewicz, Medical University of Gdansk, Gdansk; Bogdan Malkowski, Centre of Oncology, Bydgoszcz, Poland; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle,... Authors' Affiliations: 1Clinical Research Division; 2SWOG Statistical Center, Fred Hutchinson Cancer Research Center; 3Medical Oncology, University of Washington Medical Center, Seattle, Washington; 4Department of Pathology; 5Arizona Cancer Center, University of Arizona, Tucson, Arizona; 6James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester; 7Roswell Park Cancer Institute, Buffalo, New York; 8Cancer and Leukemia Group B; 9University of Michigan, Ann Arbor, Michigan; 10Department of Pathology, Oregon Health and Science University, Portland, Oregon; 11Georgetown University Hospital, Washington; 12Wichita Community Clinical Oncology Program, Wichita, Kansas; and 13Fox Chase Cancer Center-Temple Health, Temple University, Philadelphia PA.; Authors' Affiliations: 1Clinical Research Division; 2SWOG Statistical Center, Fred Hutchinson Cancer Research Center; 3Medical Oncology, University of Washington Medical Center, Seattle, Washington; 4Department of Pathology; 5Arizona Cancer Center, University of Arizona, Tucson, Arizona; 6James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester; 7Roswell Park Cancer Institute, Buffalo, New York; 8Cancer and Leukemia Group B; 9University of Michigan, Ann Arbor, Michigan; 10Department of Pathology, Oregon Health and Science University, Portland, Oregon; 11Georgetown University Hospital, Washington; 12Wichita Community Clinical Oncology Program, Wichita, Kansas; and 13Fox Chase Cancer Center-Temple Health, Temple University, Philadelphia PA. 2Roswell Park Cancer Institute, Buffalo, New York 1Medicine, Departments of; 2Immunology, and Departments of Medicine,; Immunology, and From The Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Roswell Park Cancer Institute, Buffalo, NY; University of Alabama at Birmingham, Birmingham, AL; University of Pennsylvania Abramson Cancer Center; Fox Chase Cancer Center, Philadelphia, PA; Feinberg School of Medicine, Northwestern University, Chicago, IL; Wyeth Research, Cambridge, MA; The University of Texas M.D. Anderson Cancer Center, Houston, TX; Centre Hospitalier Lyon-Sud, Pierre-Bénite; Hôpital Saint Louis, Paris, France; University... Department of Medical Oncology and Immunology Roswell Park Cancer Institute Buffalo New York Lymphoma/Myeloma Section, Roswell Park Cancer institute, Elm and Carton Streets, Buffalo, NY 14263, USA. myron.czuczman@roswellpark.org From the Division of Internal Medicine and Hematology and Department of Radiology, Nuclear Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN; Division of Hematology/Oncology and The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; M.D. Anderson Cancer Center, Houston, TX; Roswell Park Cancer Center, Buffalo, NY; University of California Los Angeles Medical Center, Los Angeles, IDEC Pharmaceuticals Corporation, San Diego, and Clinical Research and Regulatory... SUNY at Buffalo School of Medicine, Buffalo, NY. Medical Oncology and Immunology, Roswell Park Cancer Institute, Buffalo, NY; Department of Medicine Roswell Park Cancer Institute Buffalo NY USA; Department of Immunology Roswell Park Cancer Institute Buffalo NY USA Lymphoma/Myeloma Service, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY Departments of Medicine and Immunology, From the Roswell Park Cancer Institute, Buffalo, NY; University of California, Los Angeles; Biogen Idec, San Diego, CA; Mayo Clinic, Rochester, MN; and Northwestern University, Chicago, IL Roswell Park Cancer Institute Buffalo NY USA From the Departments of Medicine, Pharmacology and Therapeutics, Biostatistics, and Pathology, Roswell Park Cancer Institute, Buffalo, NY; Celgene Corporation, Summit, NJ; and Toronto Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada Roswell Park Cancer Institute, Buffalo, NY Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY Authors' Affiliations: Departments of 1Immunology and 2Medical Oncology, Roswell Park Cancer Institute, Buffalo; and 3Memorial Sloan-Kettering Cancer Center, New York, New York; Authors' Affiliations: Departments of 1Immunology and 2Medical Oncology, Roswell Park Cancer Institute, Buffalo; and 3Memorial Sloan-Kettering Cancer Center, New York, New York Department of Medicine; Roswell Park Cancer Institute; Buffalo NY USA Lymphoma/Myeloma Service, Roswell Park Cancer Institute, Buffalo, NY; From the Mayo Clinic, Rochester, MN; Johns Hopkins Oncology Center, Baltimore, MD; Northwestern University/Robert H. Lurie Cancer Center, Chicago, IL; University of California, Los Angeles, and IDEC Pharmaceuticals Corporation, San Diego, CA; Roswell Park Cancer Institute, Buffalo, NY; University of Alabama, Birmingham, AL; and Indiana Cancer Pavilion, Indianapolis, IN. Celgene, Summit, NJ Department of Internal Medicine, Mayo Clinic, Rochester, MN, Celgene Corporation, Summit, NJ, USA Departments of Medicine; Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA From the Division of Hematology, Mayo Clinic, Rochester, MN; Roswell Park Cancer Institute, Buffalo, NY. Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. myron.czuczman@roswellpark.org 2Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York.; 3Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York. Roswell Park Cancer Institute Buffalo New York From the Departments of Medicine, Health Behavior, Radiology, and Pathology, Roswell Park Cancer Institute, Buffalo, NY; Division of Hematology, New York University, New York, NY; and Celgene Corporation, Summit, NJ. 5Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York. Department of Hematology and Oncology Roswell Park Cancer Institute Buffalo NY USA Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA. From the Stanford University, Stanford; IDEC Pharmaceuticals Corp, San Diego, CA; University of Texas M.D. Anderson Cancer Center, Houston, TX; Roswell Park Cancer Center, Buffalo, NY; University of Iowa, Iowa City, IA; and Fred Hutchinson Cancer Research Center, Seattle, WA. 1Roswell Park Cancer Institute, Buffalo, New York. From the Roswell Park Cancer Institute, Buffalo, NY; Biogen Idec Inc, San Diego, CA; Mayo Clinic, Rochester, MN; University of Nebraska, Omaha, NE; M.D. Anderson Cancer Center, Houston, TX; University of California Los Angeles, Los Angeles, CA; Arizona Cancer Center, Tucson, AZ; Duke University, Durham, NC; Cornell Medical Center, New York, NY; Northwestern University, Chicago, IL; and University of Colorado Health Sciences Center, Aurora, CO Celgene, Summit, New Jersey, USA Roswell Park Cancer Institute, Buffalo, NY, USA From the Roswell Park Cancer Institute, Buffalo, NY; Biogen Idec, Cambridge, MA; and Neoplastic and Autoimmune Diseases Research Institute, Rancho Santa Fe, CA Department of Medicine & Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA 1Departments of Medicine and; 2Immunology, Roswell Park Cancer Institute, and; 3School of Medicine, State University of New York at Buffalo, Buffalo, New York 1Immunology and Departments of; 2Medicine, Roswell Park Cancer Institute, Buffalo, New York Department of Hematology and Oncology Roswell Park Cancer Institute Buffalo New York Lymphoma/Myeloma Service and Lymphoma Translational Research Laboratory, Roswell Park Cancer Institute, Buffalo, New York, USA. 1Medicine and Departments of; 3School of Medicine, State University of New York at Buffalo, Buffalo, New York |
Incoming Links
Total number of triples: 178.